Thoracic Surgery
The department performs >1000 operations per year within thoracic surgery.
We perform treatment within e.g. lung cancer (including VATS, lobectomies, pneumonectomies, chest wall resections, segmentectomies), metastasectomies, esophageal cancer, pneumothorax, emphyema, trauma (incl. chest wall stabilization), tracheal resections, sympatectomies, endobronchiale valves (EBV), lung biopsy, pectus excavatum and pectus carinatum.

Many operations are performed as key hole surgery (Video Assisted Thoracic Surgery (VATS)).

Vascular Surgery
As part of a major tertiary referral hospital, the department treats multiple acute and chronic vascular disorders. The vascular surgery team offers endovascular, open surgical, as well as hybrid treatments for peripheral vascular disease, extracranial carotid disease and aortic repair. It is the national referral centre for complex aortic disease, e.g., juxta/pararenal abdominal aortic aneurysms and thoracoabdominal aortic aneurysms, as well as aortic infections (mycotic aneurysms). The department is also integrally involved with several multi-disciplinary teams, including diabetic  wound care, complex oncological surgery, cerebrovascular and renovascular disease.

The outpatient clinic provides evaluation of referred patients, as well as routine follow-up for previously referred and/or treated patients with routine access to core vascular laboratory diagnostic tools, such as ultrasound equipment and ankle/toe blood pressure evaluation.

Access to modern open and endovascular surgical theatres is available  every day, while advanced hybrid and endovascular procedures take place in the hybrid suite, available 2-3 times per week. In addition to routine availability of mobile C-arm fluoroscopy in all operating rooms, the hybrid suite provides modern utilization of fusion imaging technology for complex endovascular procedures.

Centre for Oral Anticoagulation Therapy
The Centre provides selection, teaching, follow-up and monitoring of patients prescribed with Vitamin K-antagonist (e.g. Warfarin (Marevan®)). It implies both children and adults, and approximately 1500 patients are currently affiliated to the Centre.

For more information contact Thomas Decker Christensen, Consultant, Ass. Professor, MD, DMSc, PhD. E-mail: or Marianne Maegaard, RN. E-mail: